期刊文献+

促红细胞生成素在临床中的应用进展 被引量:1

下载PDF
导出
摘要 最早发现应用到临床的造血因子中就有促红细胞生成素,其右让祖细胞成熟、分化、增殖、存活,可以有效地增加患者血液中的红细胞的数值。其大部分是在肾脏中合成的,巨噬细胞、肝脏也可产生少量EPO。近期已经证明其还有很多其他的作用,其还能够进行免疫调节、对患者的各个器官进行保护的功效。本文就其目前在临床中的应用进展作一综述。
作者 黄舒 陈林
出处 《医学信息(中旬刊)》 2011年第2期468-469,共2页 Medical Information Operations Sciences Fascicule
  • 相关文献

参考文献3

二级参考文献12

  • 1Levey AS, Greene T, Kusek JW, et al. A simplifyied equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol, 2001, 11 : A0828 (abstract).
  • 2Rossing P, Rossing K, Gaede P, et al. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care, 2006, 29: 1024- 1030.
  • 3Thomas MC, Thomas M, Tsalamandris, Maxzsaac, et al. Anemia in diabetes : an emerging complication of microvaseular disease. Current Diabet Rev, 2005, ( 1 ) : 107 - 126.
  • 4Sinclair SH. Diabetic macular edema: New concepts of pathology and treatment. Semin Ophthalmol, 1999, 14: 197- 199.
  • 5Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neo- vascularization in vivo by inhibition of vascular endothelial growth factor (VEFG) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA,1995, 92:10457 - 10461.
  • 6Friedman EA, LEsperance FA, Brown CD, et al. Treating azotemiainduced anemia with erythropoietin improves diabetic eye disease. Kidney Int,2003, (Suppl) (87), S57 - 63.
  • 7Berman DH, Friedman EA. Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythrepoietin. Retina, 1994, 14 : 1 - 5.
  • 8Friedman EA, Brown CD, Berman DH. Erythropoietin in diabetic macular edema and renal insufficiency. Am J Didney Dis, 1995,26: 202 - 208.
  • 9Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in nor- motensive men with wen-controlled type 2 diabetes: importantce of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care, 2001,2:5 - 10.
  • 10Sarnak MJ, Leey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease. High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, 2003,108 : 254 - 2169.

共引文献21

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部